1
|
Coexpression of Gas6/Axl in human ovarian cancers.
|
Oncology
|
2004
|
1.23
|
2
|
Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells.
|
Cancer Sci
|
2004
|
1.03
|
3
|
Microbiology of Bartholin's gland abscess in Japan.
|
J Clin Microbiol
|
2005
|
0.97
|
4
|
Preventive effect of Juzen-taiho-to on endometrial carcinogenesis in mice is based on Shimotsu-to constituent.
|
Biol Pharm Bull
|
2004
|
0.96
|
5
|
Overexpression of inhibitor of DNA-binding (ID)-1 protein related to angiogenesis in tumor advancement of ovarian cancers.
|
BMC Cancer
|
2009
|
0.96
|
6
|
Expression of estrogen receptor alpha and beta in myometrium of premenopausal and postmenopausal women.
|
Steroids
|
2003
|
0.94
|
7
|
Clinical implications of steroid receptor coactivator (SRC)-3 in uterine endometrial cancers.
|
J Steroid Biochem Mol Biol
|
2007
|
0.94
|
8
|
Clinical implications of expression of ETS-1 related to angiogenesis in metastatic lesions of ovarian cancers.
|
Oncology
|
2004
|
0.93
|
9
|
Osteopontin in metastatic lesions as a prognostic marker in ovarian cancers.
|
J Biomed Sci
|
2007
|
0.93
|
10
|
Clinical implication of estrogen-related receptor (ERR) expression in ovarian cancers.
|
J Steroid Biochem Mol Biol
|
2007
|
0.90
|
11
|
Penetration of ravuconazole, a new triazole antifungal, into rat tissues.
|
Chemotherapy
|
2002
|
0.89
|
12
|
Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
|
Gynecol Oncol
|
2009
|
0.87
|
13
|
Sex steroid-dependent angiogenesis in uterine endometrial cancers.
|
J Steroid Biochem Mol Biol
|
2005
|
0.86
|
14
|
Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.
|
Int J Oncol
|
2005
|
0.84
|
15
|
Translocation of lysophosphatidic acid phosphatase in response to gonadotropin-releasing hormone to the plasma membrane in ovarian cancer cell.
|
Am J Obstet Gynecol
|
2004
|
0.83
|
16
|
Expression of interferon-gamma-inducible protein 10 related to angiogenesis in uterine endometrial cancers.
|
Oncology
|
2008
|
0.82
|
17
|
Estrogen-related receptor expression in placenta throughout gestation.
|
J Steroid Biochem Mol Biol
|
2005
|
0.82
|
18
|
Clinical implications of expression of ETS-1 in relation to angiogenesis in ovarian cancers.
|
Cancer Sci
|
2003
|
0.82
|
19
|
Drastic decrease of progesterone receptor form B but not A mRNA reflects poor patient prognosis in endometrial cancers.
|
Gynecol Oncol
|
2004
|
0.82
|
20
|
Clinical implications of osteopontin in metastatic lesions of uterine cervical cancers.
|
Cancer Lett
|
2006
|
0.82
|
21
|
Direct protection by a gonadotropin-releasing hormone analog from doxorubicin-induced granulosa cell damage.
|
Gynecol Obstet Invest
|
2006
|
0.81
|
22
|
Anti-tumor effects of herbal medicines on endometrial carcinomas via estrogen receptor-alpha-related mechanism.
|
Oncol Rep
|
2006
|
0.81
|
23
|
Expression of cyclooxygenase-2 related to angiogenesis in uterine cervical cancers.
|
J Biomed Sci
|
2006
|
0.80
|
24
|
Uterine contractions might increase heart preload in the recipient fetus in early-onset twin-twin transfusion syndrome: an ultrasound assessment.
|
Prenat Diagn
|
2004
|
0.80
|
25
|
Clinical implications of the expression of estrogen receptor-alpha and -beta in primary and metastatic lesions of uterine endometrial cancers.
|
Oncology
|
2002
|
0.80
|
26
|
Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in ovarian cancer.
|
Oncol Rep
|
2006
|
0.80
|
27
|
Penetration into and exposure of cefozopran in pelvic retroperitoneal space exudate.
|
J Infect Chemother
|
2008
|
0.80
|
28
|
[Two cases of Bartholin's gland abscesses caused by Streptococcus pneumoniae and Haemophilus influenzae].
|
Jpn J Antibiot
|
2005
|
0.80
|
29
|
Expression of ETS-1 related to angiogenesis in uterine endometrium during the menstrual cycle.
|
J Biomed Sci
|
2003
|
0.79
|
30
|
Gonadotrophin-releasing hormones agonist therapy increases peritoneal fibrinolytic activity and prevents adhesion formation after myomectomy.
|
J Obstet Gynaecol
|
2003
|
0.79
|
31
|
Plausible linkage of hypoxia-inducible factor (HIF) in uterine endometrial cancers.
|
Oncology
|
2007
|
0.78
|
32
|
PTEN sensitizes epidermal growth factor-mediated proliferation in endometrial carcinoma cells.
|
Oncol Rep
|
2006
|
0.78
|
33
|
[Prevalence and treatment of pharyngeal Chlamydia trachomatis infections].
|
Jpn J Antibiot
|
2006
|
0.78
|
34
|
Leptin as an acute stress-related hormone in the fetoplacental circulation.
|
Obstet Gynecol
|
2002
|
0.78
|
35
|
Intratumoral level of gonadotropin-releasing hormone in ovarian and endometrial cancers.
|
Oncol Rep
|
2002
|
0.78
|
36
|
Role of inhibitor of DNA binding-1 protein is related to angiogenesis in the tumor advancement of uterine endometrial cancers.
|
Exp Ther Med
|
2010
|
0.78
|
37
|
Intravaginal bacterial flora in patients with uterine cervical cancer. High incidence of detection of Gardnerella vaginalis.
|
J Infect Chemother
|
1999
|
0.78
|
38
|
Clinical efficacy of clarithromycin against uterine cervical and pharyngeal Chlamydia trachomatis and the sensitivity of polymerase chain reaction to detect C. trachomatis at various time points after treatment.
|
J Infect Chemother
|
2003
|
0.78
|
39
|
Cavernous lymphangioma arising from uterine corpus.
|
Gynecol Oncol
|
2003
|
0.77
|
40
|
MRI during pregnancy.
|
J Perinat Med
|
2003
|
0.77
|
41
|
Membrane-associated serine/threonine protein phosphatase in endometrial cancer.
|
Am J Obstet Gynecol
|
2003
|
0.77
|
42
|
Independent action of serine/threonine protein phosphatase in ovarian cancer plasma membrane and cytosol during gonadotropin-releasing hormone stimulation.
|
Oncol Rep
|
2003
|
0.77
|
43
|
Plausible linkage of hypoxia inducible factor-1alpha in uterine cervical cancer.
|
Cancer Sci
|
2006
|
0.77
|
44
|
Shimotsu-to is the agent in Juzen-taiho-to responsible for the prevention of endometrial carcinogenesis in mice.
|
Cancer Lett
|
2002
|
0.77
|
45
|
Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers.
|
Oncol Rep
|
2007
|
0.77
|
46
|
Association of cellular apoptosis with anti-tumor effects of the Chinese herbal complex in endocrine-resistant cancer cell line.
|
Cancer Detect Prev
|
2003
|
0.76
|
47
|
[Anaerobic abscess].
|
Nihon Rinsho
|
2003
|
0.76
|
48
|
In vitro stimulation of granulosa cells by a combination of different active ingredients of unkei-to.
|
Am J Chin Med
|
2004
|
0.76
|
49
|
Inhibitory effects of Hochu-ekki-to on endometrial carcinogenesis induced by N-methyl-N-nitrosourea and 17beta-estradiol in mice.
|
Oncol Rep
|
2006
|
0.76
|
50
|
Prognostic implications of cimetidine on advanced serous ovarian carcinoma related to cyclooxygenase-2 expression.
|
Mol Med Rep
|
2011
|
0.76
|
51
|
Expression of E26 transformation specific (ETS-1) related to angiogenesis in ovarian endometriosis.
|
Fertil Steril
|
2004
|
0.76
|
52
|
Expression of estrogen receptor beta exon-deleted variant mRNAs in ovary and uterine endometrium.
|
J Steroid Biochem Mol Biol
|
2003
|
0.76
|
53
|
Divalent hammerhead ribozyme targeting template region of human telomerase RNA has potent cleavage activity, but less inhibitory activity on telomerase.
|
Arch Biochem Biophys
|
2002
|
0.75
|
54
|
Role of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers.
|
BMC Cancer
|
2008
|
0.75
|
55
|
In vitro and in vivo antibacterial activities of telithromycin.
|
Chemotherapy
|
2003
|
0.75
|
56
|
Preventive effects of glycyrrhizin on estrogen-related endometrial carcinogenesis in mice.
|
Oncol Rep
|
2007
|
0.75
|
57
|
Evidence for hormone-responsive cleavage of gonadotropin-releasing hormone by the plasma membrane of ovarian cancer cells.
|
Int J Oncol
|
2002
|
0.75
|
58
|
Effects of various steroids on platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA expression in uterine endometrial cancer cells.
|
J Steroid Biochem Mol Biol
|
2003
|
0.75
|
59
|
Advanced indications for gonadotropin-releasing hormone (GnRH) analogues in gynecological oncology (review).
|
Int J Oncol
|
2003
|
0.75
|
60
|
Evidence for tight coupling of Gi protein-mediated lysophosphatidic acid receptor to stimulated cytokine production in ovarian cancer cell.
|
Am J Obstet Gynecol
|
2004
|
0.75
|
61
|
Tuboovarian abscess caused by Candida glabrata in a febrile neutropenic patient.
|
J Infect Chemother
|
2003
|
0.75
|
62
|
Efficacy of micafungin against deep-seated candidiasis in cyclophosphamide-induced immunosuppressed mice.
|
J Antimicrob Chemother
|
2005
|
0.75
|
63
|
Gonadotropin-releasing hormone retards doxorubicin-induced apoptosis and serine/threonine phosphatase inhibition in ovarian cancer cells.
|
Oncol Rep
|
2005
|
0.75
|
64
|
Penetration of oral telithromycin into female genital tissues.
|
J Infect Chemother
|
2003
|
0.75
|
65
|
[Clinical investigation on administration method of gatifloxacin based on PK/PD theory].
|
Jpn J Antibiot
|
2006
|
0.75
|
66
|
Pharmacokinetics of single-dose intravenous ciprofloxacin in blood and ascites of patients with pelvic peritonitis.
|
J Infect Chemother
|
2003
|
0.75
|
67
|
Puerperal intrauterine infection caused by Edwardsiella tarda.
|
J Infect Chemother
|
2003
|
0.75
|
68
|
[Effectiveness of switch therapy for peritonitis].
|
Jpn J Antibiot
|
2007
|
0.75
|
69
|
Topical vidarabine or 5-fluorouracil treatment against persistent HPV in genital (pre)cancerous lesions.
|
Oncol Rep
|
2003
|
0.75
|
70
|
Quantitative analysis of estrogen receptor proteins in rat ovary.
|
J Steroid Biochem Mol Biol
|
2005
|
0.75
|
71
|
[Investigation on administration method of carbapenems].
|
Jpn J Antibiot
|
2002
|
0.75
|
72
|
Inhibitory effects of toremifene on N-methyl-N-nitrosourea and estradiol-17beta-induced endometrial carcinogenesis in mice.
|
Jpn J Cancer Res
|
2002
|
0.75
|
73
|
Nosocomial infectious potency of imipenem-resistant Pseudomonas aeruginosa isolated from obstetric and gynecologic infections.
|
J Infect Chemother
|
2003
|
0.75
|